Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Inventory (2024 - 2025)

Insight Molecular Diagnostics (IMDX) has disclosed Inventory for 2 consecutive years, with $446000.0 as the latest value for Q4 2025.

  • Quarterly Inventory rose 8.78% to $446000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $446000.0 through Dec 2025, up 8.78% year-over-year, with the annual reading at $446000.0 for FY2025, 8.78% up from the prior year.
  • Inventory hit $446000.0 in Q4 2025 for Insight Molecular Diagnostics, down from $471000.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $693000.0 in Q2 2025 to a low of $232000.0 in Q3 2024.